DoP, BSE sign MoU to expand Mutual Fund Access Across India (See 'Corp Brief') Cloud data centre capacity in India estimated to grow 4 to 5 times by 2030 (See 'Corp Brief') Scindia to address Gramin Dak Sevak Sammelan in Kolhapur (See 'Corp Brief') Semicon India Program developing complete ecosystem for Semiconductors (See 'Corp Brief') NITI Aayog releases report on Deepening the Corporate Bond Market in India (See 'Corp Brief') India showcases Green Hydrogen Mobility with NISE-Toyota Fuel Cell Vehicle Pilot (See 'Corp Brief') ESIC approves Annual Accounts, CAG Report, and Annual Report for 2024-25 (See 'Corp Brief') A&C - Difference or controversy as to rate of interest clearly falls outside scope of challenge on ground of conflict with public policy of India unless it is evident that rate of interest awarded is so perverse: SC (See 'Legal Desk') Goyal inaugurates NEST-02 at Santacruz Electronics Export Processing Zone (See 'Corp Brief') Steering Committee for PM Vishwakarma scheme approves several proposals (See 'Corp Brief') A & C - By awarding reimbursement for second regular meal & welcome drinks, arbitrator had created new contract between parties, amounting to breach of Sec 28(3), which is patently illegal and against public policy: SC (See 'Legal Desk') India's Food Revolution takes Centre Stage at Annapoorna Interfood 2025 (See 'Corp Brief') IBC - It is mandatory duty of RP to verify every claim received and maintain updated list of creditors with requisite details including amount admitted, claimed, and security interest: IBBI (See 'Legal Desk') NBA releases Rs.6.2 Crore as Access and Benefit Sharing funds to beneficiaries in 5 States (See 'Corp Brief') PMLA - Secured creditor can stake its claim by moving application before Special Judge, PMLA Court, even before conclusion of trial, if excess amount is realised during auction sale: SAFEMA (See 'Legal Desk') Gati Shakti Vishwavidyalaya & Amazon sign MoU to promote Knowledge Sharing (See 'Corp Brief') India-EU Ideathon on Marine Plastic Pollution concluded (See 'Corp Brief') IBC - Moratorium does not protect development rights under agreement that was validly terminated for corporate debtor's non-performance before initiation of insolvency proceedings: SC (See 'Legal Desk') 37 supercomputers with total computing power of 40 Petaflops deployed under NSM (See 'Corp Brief') Scindia highlights major expansion and modernisation of India Post Network (See 'Corp Brief') A&C - Objections to execution lie within narrow compass typically only where decree is inherently void or was rendered by a forum lacking jurisdiction and therefore cannot be used to frustrate final arbitral award: SC (See 'Legal Desk') Controller General inaugurates onboarding of MTNL Pensioners onto SAMPANN (See 'Corp Brief') Misc - Till matter is finally decided by trial court, subject matter of suit needs to be preserved: HC (See 'Legal Desk') PM-KUSUM registers Significant Progress: 10,203 MW Installed (See 'Corp Brief') Competition Law - If entities which participated in bid-rigging were cover bidders and not even present in relevant market, and their relevant turnover was nil, then their egregious nature of conduct attracts maximum penalty in terms of Sec 27(b): CCI (See 'Legal Desk') CCI okays proposed acquisition of certain stake in Schneider Electric India Pvt Ltd & Schneider Electric JV Holdings 2 Pte. Ltd. (See 'Corp Brief') CCI nod to proposed combination involving Curefit, Cultfit & Fitness First Luxembourg (See 'Corp Brief') SARFAESI - Provident fund dues must be paid out first from auction proceeds of defunct factory, ahead of claims of secured creditor (the bank), with remaining amounts to satisfy other debts: SC (See 'Legal Desk') India Post unveils Kerala's First Gen-Z Post Office Extension Counter at CMS College, Kottayam (See 'Corp Brief') Global Organic Market rises; India strengthens Exports with Revised NPOP (See 'Corp Brief') A&C - Mere use of term 'arbitration' in contractual clause does not by itself establish binding intent to arbitrate unless parties have clearly agreed to resolve their disputes through that process: SC (See 'Legal Desk') MOIL achieves Best-Ever November Production and Sales Performance (See 'Corp Brief') Power Minister commences COD of 250 MW 3rd Unit of Tehri Variable Speed PSP (See 'Corp Brief') Misc - Adequate treatment is available domestically, mere preference for foreign medical facility does not justify permitting accused facing serious economic-offence allegations to leave jurisdiction: HC (See 'Legal Desk') MoS flags Off Tirupati-Sainagar Shirdi Express (See 'Corp Brief') A&C - No party can invoke Section 11 after competent civil court has already rejected Section 8 application by holding that arbitration clause does not constitute arbitration agreement: HC (See 'Legal Desk') FAME outreach, Niveshak Didi scheme promoting safe banking practices: MoS (See 'Corp Brief') Rail Infra proposals Reviewed to Strengthen Integrated Logistics Network (See 'Corp Brief') IBC - Regulation 2B(3) will not justify unilateral forfeiture of entire Earnest Money Deposit, when scheme is rejected on technical grounds: IBBI (See 'Legal Desk') Smart Metering Adoption: 4.76 Crore Smart Meters installed (See 'Corp Brief') UDBHAV 2025: Telangana tops Medal Tally as Tribal Talent shines nationwide (See 'Corp Brief') PMLA - FIRs being fundamental documents based on which entire case was initiated by ED, failure to serve same is fatal omission on part of enforcement directorate: SAFEMA TRIBUNAL (See 'Legal Desk') Australia-India Education and Skills Council meeting to be held in New Delhi (See 'Corp Brief') RM appeals for generous contributions to Armed Forces Flag Day Fund (See 'Corp Brief') The Human Impact of Raipur-Vizag Corridor (See 'Corp Brief') A&C - Court's scope of inquiry u/s 11 is limited to prima facie examination of existence of arbitration agreement while adjudication u/s 8 is to be made for both existence & validity: HC (See 'Legal Desk') HM inaugurates newly-constructed Bio-CNG and Fertilizer Plant by Banas Dairy (See 'Corp Brief') NMDC signs MoU with IIT Kanpur to strengthen Cybersecurity (See 'Corp Brief') Misc - Decision of Lokpal cannot be challenged in judicial review if there is no procedural infirmity or irregularity in manner in which either CVC or Lokpal conducted inquiry: HC (See 'Legal Desk')

Print

Govt hosts workshop on increasing R&D in pharma-medical tech sector

Published: Mar 13, 2025

By TIOLCorplaws News Service

NEW DELHI, MAR 13, 2025: THE Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India, organised a workshop on the Promotion of Research and Innovation in Pharma-MedTech Sector (PRIP) Scheme today. The workshop was inaugurated in the presence of the Secretaries of five stakeholder Ministries and Departments of the Government of India, namely, Amit Agrawal, Secretary, Department of Pharmaceuticals; Prof. Abhay Karandikar, Secretary, Department of Science and Technology (DST); S. Krishnan, Secretary, Ministry of Electronics and Information Technology (MeitY); Dr N. Kalaiselvi, Secretary, Department of Scientific and Industrial Research (DSIR) and Director General (DG), Council of Scientific and Industrial Research (CSIR); and Dr Rajiv Bahl, Secretary, Department of Health Research (DHR) and DG, Indian Council for Medical Research (ICMR). The workshop served as a platform for identifying key action points and approaches to further the shared commitment to promote research and development in the pharmaceuticals and medical technologies sector.

Amit Agrawal, Secretary, Department of Pharmaceuticals highlighted the rapid expansion in the sector, underscoring the importance of research and innovation in driving making and innovating in India for India and the world. In this regard, he highlighted that the global share of personalised and precision technology platforms (such as antibody-drug conjugates, bi-specific antibodies, and cell and gene therapy) among the top-100 drugs by value is growing rapidly, from 5% in 2020 to 9% in 2025 and projected to grow to 20% by 2030. He also highlighted the 10 times increase in the number of Indian healthcare and life sciences startups over the last four years, from over 900 in 2020 to more than 10,000 in 2024, as well as the growing pipeline of innovative products of Indian firms.

Amit Agrawal said that the groundwork and the pipeline for projects for the PRIP scheme has been laid through this growing innovation ecosystem of Indian startups and industry, supported by a wide array of initiatives of the scientific Ministries/ Departments. The latter include the clinical trial network created by CSIR under its INTENT initiative; the patenting support available through DST's TIFAC and ICMR's Patent Mitra initiative; the handholding support available to both medical technology and drug innovations through ICMR's MedTech Mitra initiative; the funding support available to startups through Department of Biotechnology's BIRAC, MeitY's TIDE 2.0 and SAMRIDH schemes and DST's Quantum Computing Mission, etc.

Reiterating the Government's commitment to a robust research ecosystem, Amit said that PRIP is a transformative initiative aimed at catalysing innovation, strengthening industry-academia linkages, and positioning India as a global leader in pharmaceutical and MedTech research.

Prof. Abhay Karandikar, Secretary, DST underscored the importance of cutting-edge scientific research in driving advancements in pharmaceuticals and MedTech, reinforcing India's healthcare ecosystem and highlighted the supports available through the extensive incubator and accelerator network of DST.

S. Krishnan, Secretary, MeitY emphasised the transformative potential of digital health, artificial intelligence (AI) and data-driven technologies in drug discovery and medical device development. He highlighted the research strengths of MeitY's organisations, such as Society for Applied Microwave Electronics Engineering and Research (SAMEER), C-DAC and Centre for Materials for Electronics Technology (C-MET).

Dr Rajiv Bahl, Secretary, DHR and DG, ICMR highlighted the critical role of clinical research, indigenous drug development and regulatory advancements in accelerating pharmaceutical innovation. He offered the full support of the ICMR INTENT, MedTech Mitra and Patent Mitra initiatives in taking forward the shared goals of PRIP scheme. He also said that the industry-academia collaborative research window under the scheme could be of considerable help in taking forward the large volume of intramural and extramural research being funded by ICMR to the market with funding from PRIP and industry involvement.

Dr N. Kalaiselvi, Secretary, DSIR and DG, CSIR underscored the need to foster a culture of scientific collaboration between research institutions and industry to ensure the seamless translation of research into commercially viable applications. She highlighted that considerable research done in CSIR labs could be taken to the market through collaboration with industry and funding from PRIP.

The discussions reaffirmed the Government's vision of transforming India into a global hub for research and innovation in pharmaceuticals and medical technology. The workshop featured four dedicated breakout sessions, bringing together over 100 participants from leading scientific departments and premier institutions, including the National Institutes of Pharmaceutical Education and Research, IITs, CSIR labs and organisations of ICMR, MeitY, DST and Department of Bio technology, along with key government enablers for the ecosystem. Key deliberations covered the emerging trends in pharmaceutical and MedTech research, strategies for translating research into commercially viable products, government support mechanisms to accelerate sectoral growth and flexibilities sought to maximise the impact from the PRIP scheme.

All participants were requested to share their suggestions in the Expression of Interest (EoI) form for the PRIP scheme hosted on the website of the Department of Pharmaceuticals, so that these may be taken into account while taking forward the scheme and enabling participants. The EoI would be open till April 7, 2025.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.